Kelly M Bakulski1, John F Dou1, Jason I Feinberg2, Katharine K Brieger1, Lisa A Croen3, Irva Hertz-Picciotto4, Craig J Newschaffer5, Rebecca J Schmidt4, M Daniele Fallin2. 1. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA. 2. Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA. 3. Division of Research, Kaiser Permanente, Oakland, CA 94612, USA. 4. Department of Public Health Sciences and the M.I.N.D. Institute, School of Medicine, University of California, Davis, CA 95616, USA. 5. College of Health and Human Development, Penn State University, State College, PA 16802, USA.
Abstract
BACKGROUND: Fetal development involves cellular differentiation and epigenetic changes-complex processes that are sensitive to environmental factors. Maternal nutrient levels during pregnancy affect development, and methylene tetrahydrofolate reductase (MTHFR) is important for processing the nutrient folate. HYPOTHESIS: We hypothesize that supplement intake before pregnancy and maternal genotype are associated with DNA methylation in newborns. METHODS: In the pregnancy cohort, Early Autism Risk Longitudinal Investigation (EARLI), health history, and genotype information was obtained (n = 249 families). Cord blood DNA methylation (n = 130) was measured using the Illumina HumanMethylation450k array and global DNA methylation levels were computed over 455,698 sites. Supplement use preconception and during pregnancy were surveyed at visits during pregnancy. We evaluated associations between maternal preconception supplement intake and global DNA methylation or DNA methylation density distributions of newborn cord blood, stratified by the presence of a variant maternal MTHFR C677T allele. RESULTS: Maternal preconceptional multivitamin intake was associated with cord blood methylation, dependent on maternal MTHFR genotype (interaction term p = 0.013). For mothers without the MTHFR variant allele, multivitamin intake was associated with 0.96% (95% CI: 0.09, 1.83) higher global cord blood methylation (p = 0.04) and was also associated with the cumulative density distribution of methylation (p = 0.03). For mothers with at least one variant allele, multivitamin intake had a null -0.06% (95% CI: -0.45, 0.33) association with global cord blood DNA methylation, and was not associated with the cumulative density distribution (p = 0.37). CONCLUSIONS: We observed that cord blood DNA methylation was associated with maternal supplement exposure preconception and maternal genotype. Genetic context should be considered when assessing DNA methylation effects of modifiable risk factors around the time of pregnancy.
BACKGROUND: Fetal development involves cellular differentiation and epigenetic changes-complex processes that are sensitive to environmental factors. Maternal nutrient levels during pregnancy affect development, and methylene tetrahydrofolate reductase (MTHFR) is important for processing the nutrient folate. HYPOTHESIS: We hypothesize that supplement intake before pregnancy and maternal genotype are associated with DNA methylation in newborns. METHODS: In the pregnancy cohort, Early Autism Risk Longitudinal Investigation (EARLI), health history, and genotype information was obtained (n = 249 families). Cord blood DNA methylation (n = 130) was measured using the Illumina HumanMethylation450k array and global DNA methylation levels were computed over 455,698 sites. Supplement use preconception and during pregnancy were surveyed at visits during pregnancy. We evaluated associations between maternal preconception supplement intake and global DNA methylation or DNA methylation density distributions of newborn cord blood, stratified by the presence of a variant maternal MTHFRC677T allele. RESULTS: Maternal preconceptional multivitamin intake was associated with cord blood methylation, dependent on maternal MTHFR genotype (interaction term p = 0.013). For mothers without the MTHFR variant allele, multivitamin intake was associated with 0.96% (95% CI: 0.09, 1.83) higher global cord blood methylation (p = 0.04) and was also associated with the cumulative density distribution of methylation (p = 0.03). For mothers with at least one variant allele, multivitamin intake had a null -0.06% (95% CI: -0.45, 0.33) association with global cord blood DNA methylation, and was not associated with the cumulative density distribution (p = 0.37). CONCLUSIONS: We observed that cord blood DNA methylation was associated with maternal supplement exposure preconception and maternal genotype. Genetic context should be considered when assessing DNA methylation effects of modifiable risk factors around the time of pregnancy.
Entities:
Keywords:
DNA methylation; MTHFR; cord blood; multivitamin
Authors: Kelly M Bakulski; Jason I Feinberg; Shan V Andrews; Jack Yang; Shannon Brown; Stephanie L McKenney; Frank Witter; Jeremy Walston; Andrew P Feinberg; M Daniele Fallin Journal: Epigenetics Date: 2016-03-28 Impact factor: 4.528
Authors: Stephen Z Levine; Arad Kodesh; Alexander Viktorin; Lauren Smith; Rudolf Uher; Abraham Reichenberg; Sven Sandin Journal: JAMA Psychiatry Date: 2018-02-01 Impact factor: 21.596
Authors: Simonetta Friso; Sang-Woon Choi; Domenico Girelli; Joel B Mason; Gregory G Dolnikowski; Pamela J Bagley; Oliviero Olivieri; Paul F Jacques; Irwin H Rosenberg; Roberto Corrocher; Jacob Selhub Journal: Proc Natl Acad Sci U S A Date: 2002-04-02 Impact factor: 11.205
Authors: Diane I Schroeder; John D Blair; Paul Lott; Hung On Ken Yu; Danna Hong; Florence Crary; Paul Ashwood; Cheryl Walker; Ian Korf; Wendy P Robinson; Janine M LaSalle Journal: Proc Natl Acad Sci U S A Date: 2013-03-25 Impact factor: 11.205
Authors: Bonnie R Joubert; Herman T den Dekker; Janine F Felix; Jon Bohlin; Symen Ligthart; Emma Beckett; Henning Tiemeier; Joyce B van Meurs; Andre G Uitterlinden; Albert Hofman; Siri E Håberg; Sarah E Reese; Marjolein J Peters; Bettina Kulle Andreassen; Eric A P Steegers; Roy M Nilsen; Stein E Vollset; Øivind Midttun; Per M Ueland; Oscar H Franco; Abbas Dehghan; Johan C de Jongste; Michael C Wu; Tianyuan Wang; Shyamal D Peddada; Vincent W V Jaddoe; Wenche Nystad; Liesbeth Duijts; Stephanie J London Journal: Nat Commun Date: 2016-02-10 Impact factor: 14.919
Authors: Andres Cardenas; Sheryl L Rifas-Shiman; Lode Godderis; Radu-Corneliu Duca; Ana Navas-Acien; Augusto A Litonjua; Dawn L DeMeo; Kasey J Brennan; Chitra J Amarasiriwardena; Marie-France Hivert; Matthew W Gillman; Emily Oken; Andrea A Baccarelli Journal: Environ Health Perspect Date: 2017-08-29 Impact factor: 9.031
Authors: Kelly M Bakulski; Jonah D Fisher; John F Dou; Arianna Gard; Lisa Schneper; Daniel A Notterman; Erin B Ware; Colter Mitchell Journal: Toxics Date: 2021-10-13
Authors: Kelly M Bakulski; John F Dou; Jason I Feinberg; Max T Aung; Christine Ladd-Acosta; Heather E Volk; Craig J Newschaffer; Lisa A Croen; Irva Hertz-Picciotto; Susan E Levy; Rebecca Landa; Andrew P Feinberg; Margaret D Fallin Journal: Front Mol Neurosci Date: 2021-11-25 Impact factor: 5.639
Authors: Daniele Fallin; Rebecca J Schmidt; Kelly M Bakulski; John F Dou; Lauren Y M Middleton; Yihui Zhu; Kelly S Benke; Jason I Feinberg; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; Janine M LaSalle Journal: Epigenetics Chromatin Date: 2022-08-02 Impact factor: 5.465
Authors: Amanda R Jensen; Alison L Lane; Brianna A Werner; Sallie E McLees; Tessa S Fletcher; Richard E Frye Journal: Mol Diagn Ther Date: 2022-06-27 Impact factor: 4.476
Authors: Max T Aung; Kelly M Bakulski; Jason I Feinberg; John F Dou; John D Meeker; Bhramar Mukherjee; Rita Loch-Caruso; Christine Ladd-Acosta; Heather E Volk; Lisa A Croen; Irva Hertz-Picciotto; Craig J Newschaffer; M Daniele Fallin Journal: Epigenetics Date: 2021-04-02 Impact factor: 4.528